www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Companies

Biotech boom, pride of Anhui

By Zhu Lixin (China Daily) Updated: 2016-07-19 08:14

Biotech boom, pride of Anhui

A bird's-eye view of the world's largest biotech drug production base in Hefei, Anhui province. The facility is shaped in the form of antibody ATCG. [Photo provided to China Daily]

Beijing-based Sinobioway Group Co Ltd, a major biotech company in China, is building the world's largest biotech drug production base at the Bantang township in Hefei, capital of Anhui province in East China.

The facility, shaped in the form of antibody ATCG and to be called the Bantang Bioeconomy Experimental Zone, will have 100 production lines to be completed in 10 to 15 years. The first five lines will be completed by the end of this year.

Work on another 10 will also start later this year, said Cao Wenbo, president of Anhui Sinobioway Bioeconomy Group, a subsidiary of Sinobioway Group.

The zone covers an area of 31 sq km. A 400,000-sq-meter plant is almost ready; the next two phases will take up 600,000 sq m.

Cao said infrastructure excluding the production lines will see an investment of 1.5 billion yuan ($224.3 million), which is being provided by the Hefei government.

Wu Cunrong, Party chief of Hefei city, said: "We believe the biotech drug sector will see enormous growth opportunities in future, so we will surely support such companies."

The company, Cao said, will repay the money in five years "so that we can have more money for mergers and acquisitions. We have enough money to reach the goal."

There are dozens of funds to back the ambitious project, which is expected to cost billions of yuan, he said.

"Instead of starting from the R&D stage, Sinobioway is more interested in buying drug patents and firms at home and abroad. Biotech drug production has been very profitable. But starting everything from R&D will be too time-consuming and risky. You may spend years but get nothing."

He said buying patents and firms will bring the company high profits quickly. During the process, it will also develop its own drugs.

This business model has marked the collaboration between Sinobioway and BioAlta, a San Diego-based company focused on the development of Conditionally Active Biologic antibody therapeutics.

In 2015, the two companies forged a strategic collaboration for the development and commercialization of select CAB antibodies and other CAB-based therapeutics in China. "Production of all the drugs will be based in Hefei," said Cao.

BioAlta would receive more than $70 million in payments and investment from Sinobioway in a year, according to their agreement.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 黄人成a动漫片免费网站 | 国产精品久久大陆 | 色综合a怡红院怡红院首页 色综合精品久久久久久久 色综合九九 | 日本高清色本在线www游戏 | 欧美一级永久免费毛片在线 | 四虎午夜剧场 | 欧美成免费 | 草草影院在线观看 | 国产精彩视频在线观看 | 日本b站一卡二卡乱码入口 日本s色大片在线观看 | 免费一级片网站 | 成年人免费观看网站 | 视频在线一区二区三区 | 欧美日韩一区二区三区在线 | 国产黄色小视频 | 成人久久18免费网 | 中文字幕成人网 | 中文字幕国产一区 | 免费观看a级网站 | 欧美h版成版在线观看 | 亚洲精品综合在线 | 国产精品亚洲第一区二区三区 | 日韩亚洲欧美一区二区三区 | 欧美福利一区二区三区 | 女人18毛片a级毛片 女人aaaaa片一级一毛片 | 国产一二三区视频 | 伊人55影院| 亚洲一区二区三区不卡视频 | 国产精品一区二区资源 | 亚洲性久久久影院 | 亚洲欧美精品 | 正能量www正能量免费网站 | 黄影院 | 高清国产在线播放成人 | 久久99国产亚洲精品 | 在线欧美日韩精品一区二区 | 玖玖精品视频在线 | 亚洲天堂爱爱 | 欧美国产日本高清不卡 | 三级免费毛片 | 成人午夜视频一区二区国语 |